Package 0615-8326-39
Brand: divalproex sodium
Generic: divalproex sodiumPackage Facts
Identity
Package NDC
0615-8326-39
Digits Only
0615832639
Product NDC
0615-8326
Description
30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-8326-39)
Marketing
Marketing Status
Brand
divalproex sodium
Generic
divalproex sodium
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5b31a69e-8500-4895-9429-4a3f600bbc72", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099625", "1099678", "1099870"], "spl_set_id": ["0f86c2ad-a13c-457d-8fed-6c3f470a470d"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-8326-39)", "package_ndc": "0615-8326-39", "marketing_end_date": "20260531", "marketing_start_date": "20200106"}], "brand_name": "Divalproex Sodium", "product_id": "0615-8326_5b31a69e-8500-4895-9429-4a3f600bbc72", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "0615-8326", "generic_name": "Divalproex Sodium", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex Sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "125 mg/1"}], "application_number": "ANDA078182", "marketing_category": "ANDA", "marketing_end_date": "20260531", "marketing_start_date": "20140321"}